CC chemokine receptors and chronic inflammation—therapeutic opportunities and pharmacological challenges
Chemokines are a family of low molecular weight proteins with an essential role in leukocyte
trafficking during both homeostasis and inflammation. The CC class of chemokines consists …
trafficking during both homeostasis and inflammation. The CC class of chemokines consists …
[HTML][HTML] Chemokines and chemokine receptors in arthritis
Z Szekanecz, A Vegvari, Z Szabo… - Frontiers in bioscience …, 2010 - ncbi.nlm.nih.gov
Chemokines are involved in leukocyte recruitment to inflammatory sites, such as the
synovial tissue in rheumatoid arthritis (RA). There is a structural and a functional …
synovial tissue in rheumatoid arthritis (RA). There is a structural and a functional …
[PDF][PDF] Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components
X Chen, JJ Oppenheim, OM Howard - Cell Mol Immunol, 2004 - cmi.ustc.edu.cn
Chemokines are chemoattractant cytokines that direct the migration of leukocytes, and are
induced by inflammatory cytokines, growth factors and pathogenic stimuli (1). Chemokines …
induced by inflammatory cytokines, growth factors and pathogenic stimuli (1). Chemokines …
Can we target CCR2 to treat osteoarthritis? The trick is in the timing!
RE Miller, AM Malfait - Osteoarthritis and cartilage, 2017 - oarsijournal.com
CeC motif chemokines, including CCL2, CCL7, and CCL12, affect cells that express the
CeC chemokine receptor type 2, CCR2, a seven-transmembrane domain G-protein coupled …
CeC chemokine receptor type 2, CCR2, a seven-transmembrane domain G-protein coupled …
Rheumatoid arthritis: pathogenesis and therapeutic advances
Y Gao, Y Zhang, X Liu - MedComm, 2024 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the unresolved
synovial inflammation for tissues‐destructive consequence, which remains one of significant …
synovial inflammation for tissues‐destructive consequence, which remains one of significant …
Promising therapeutic targets for treatment of rheumatoid arthritis
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that
mainly damages the hands and feet, which affects 0.5% to 1.0% of the population …
mainly damages the hands and feet, which affects 0.5% to 1.0% of the population …
Therapeutic inhibition of leukocyte recruitment in inflammatory diseases
Z Szekanecz, AE Koch - Current Opinion in Pharmacology, 2004 - Elsevier
The ingress of leukocytes into sites of inflammation is crucial for the pathogenesis of arthritis
and other inflammatory conditions. Chemokines, their receptors and cellular adhesion …
and other inflammatory conditions. Chemokines, their receptors and cellular adhesion …
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Q Ding, W Hu, R Wang, Q Yang, M Zhu, M Li… - Signal transduction and …, 2023 - nature.com
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease
progression leads to joint deformity and associated loss of function, which significantly …
progression leads to joint deformity and associated loss of function, which significantly …
Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3
T Montero-Melendez, RAE Forfar, JM Cook… - Cellular and Molecular …, 2017 - Springer
The efficiency of drug research and development has paradoxically declined over the last
decades despite major scientific and technological advances, promoting new cost-effective …
decades despite major scientific and technological advances, promoting new cost-effective …
Targeting granulocyte-monocyte colony-stimulating factor signaling in rheumatoid arthritis: future prospects
C Crotti, E Agape, A Becciolini, M Biggioggero… - Drugs, 2019 - Springer
Rheumatoid arthritis (RA) is a systemic, autoimmune disease that affects joints and extra-
articular structures. In the last decade, the management of this chronic disease has …
articular structures. In the last decade, the management of this chronic disease has …